Hsbc Holdings PLC Purchases New Stake in IDEX Corporation $IEX

Hsbc Holdings PLC acquired a new position in IDEX Corporation (NYSE:IEX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 403,063 shares of the industrial products company’s stock, valued at approximately $91,474,000.

A number of other institutional investors have also recently bought and sold shares of the business. Laurel Wealth Advisors LLC purchased a new position in IDEX during the 4th quarter valued at about $27,000. Optiver Holding B.V. purchased a new stake in shares of IDEX in the first quarter worth approximately $27,000. SJS Investment Consulting Inc. lifted its position in shares of IDEX by 104.1% in the first quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 76 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of IDEX during the second quarter worth approximately $33,000. Finally, CYBER HORNET ETFs LLC acquired a new stake in shares of IDEX during the second quarter worth approximately $35,000. 97.96% of the stock is currently owned by institutional investors and hedge funds.

Get IDEX alerts:

IDEX Stock Up 2.0%

Shares of IDEX stock opened at $234.91 on Thursday. The firm has a market cap of $17.32 billion, a price-to-earnings ratio of 33.80, a P/E/G ratio of 2.17 and a beta of 0.98. The stock has a 50-day simple moving average of $228.47 and a 200-day simple moving average of $213.48. IDEX Corporation has a 52-week low of $158.19 and a 52-week high of $243.80. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15.

IDEX (NYSE:IEX – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, topping analysts’ consensus estimates of $2.11 by $0.21. The firm had revenue of $920.60 million for the quarter, compared to the consensus estimate of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The firm’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, equities research analysts expect that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.

IDEX Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were paid a dividend of $0.73 per share. The ex-dividend date was Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. IDEX’s dividend payout ratio is 42.01%.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Stifel Nicolaus boosted their price objective on shares of IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Royal Bank Of Canada increased their target price on shares of IDEX from $261.00 to $280.00 and gave the stock an “outperform” rating in a research report on Thursday, July 30th. Oppenheimer reissued an “outperform” rating and set a $265.00 target price on shares of IDEX in a research note on Thursday, July 30th. Seaport Research Partners restated a “buy” rating and set a $250.00 price target on shares of IDEX in a report on Tuesday, May 5th. Finally, Citigroup upped their price target on shares of IDEX from $252.00 to $269.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $260.80.

View Our Latest Stock Report on IEX

Insider Activity at IDEX

In other news, CAO Lisa M. Anderson sold 385 shares of the firm’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer owned 4,327 shares in the company, valued at approximately $1,032,378.93. This trade represents a 8.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.50% of the stock is currently owned by company insiders.

IDEX News Summary

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
• Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
• Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
• Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
• Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
• Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

IDEX Profile

(Free Report)

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

Featured Stories

• Five stocks we like better than IDEX
• Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
• Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
• Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
• Can Tesla’s Flying Roadster Distract From Its Real Risks?

Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.